Abstract:Abstract Endometriosis is a common chronic inflammatory condition in which endometrial tissue appears outside the uterine cavity. Because ectopic endometriosis cells express both estrogen and progesterone (P4) receptors, they grow and undergo cyclic proliferation and breakdown similar to the endometrium. This debilitating gynecological disease affects up to 15% of reproductive aged women. Despite many years of research, the etiopathogenesis of endometrial lesions remains unclear. Retrograde transport of the viable menstrual endometrial cells with retained ability for attachment within the pelvic cavity, proliferation, differentiation and subsequent invasion into the surrounding tissue constitutes the rationale for widely accepted implantation theory. Accordingly, the most abundant cells in the endometrium are endometrial stromal cells (EnSCs). These cells constitute a particular population with clonogenic activity that resembles properties of mesenchymal stem/stromal cells (MSCs). Thus, a significant role of stem cell-based dysfunction in formation of the initial endometrial lesions is suspected. There is increasing evidence that the role of epigenetic mechanisms and processes in endometriosis have been underestimated. The importance of excess estrogen exposure and P4 resistance in epigenetic homeostasis failure in the endometrial/endometriotic tissue are crucial. Epigenetic alterations regarding transcription factors of estrogen and P4 signaling pathways in MSCs are robust in endometriotic tissue. Thus, perspectives for the future may include MSCs and EnSCs as the targets of epigenetic therapies in the prevention and treatment of endometriosis. Here, we reviewed the current known changes in the epigenetic background of EnSCs and MSCs due to estrogen/P4 imbalances in the context of etiopathogenesis of endometriosis.

Epigenetics of Estrogen and Progesterone Receptors in Endometriosis

GPR30-mediated non-classic estrogen pathway in mast cells participates in endometriosis pain <i>via</i> the production of FGF2

Nlrp3 Inflammasome Activation Of Mast Cells By Estrogen Via The Nuclear-Initiated Signaling Pathway Contributes To The Development Of Endometriosis

Estrogen is an Important Mediator of Mast Cell Activation in Ovarian Endometriomas

The Epigenetics of Endometriosis

Epigenetic dysregulation of endometriosis susceptibility genes (Review).

Promoter Hypermethylation of Progesterone Receptor Isoform B (Pr-B) in Endometriosis.

Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis

Endometriosis: Update of Pathophysiology, (Epi) Genetic and Environmental Involvement

MicroRNAs and Progesterone Receptor Signaling in Endometriosis Pathophysiology

Estrogen- and Progesterone (P4)-Mediated Epigenetic Modifications of Endometrial Stromal Cells (EnSCs) and/or Mesenchymal Stem/Stromal Cells (MSCs) in the Etiopathogenesis of Endometriosis

Immune and endocrine regulation in endometriosis: what we know

Molecular Biology of Endometriosis: From Aromatase to Genomic Abnormalities

Progesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives

Reduced Alternative Splicing of Estrogen Receptor Alpha in the Endometrium of Women with Endometriosis.

[Research Progress on Epigenetics in Endometriosis].

MicroRNAs in Endometriosis: Insights into Inflammation and Progesterone Resistance

The role of peroxisome proliferator-activated receptors in endometriosis

Follicular Fluid Progesterone Downregulated HPGD and COX2 in Granulosa Cells Via Suppressing NF-ĸB in Endometriosis

Progress in Research on Epigenetics of Endometriosis-Associated Infertility

Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target